LINDSAY LEE: Open Payments
NPI 1538451943 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 7 payments from 6 companies in 2025. Trend: 2023 $1,864 · 2024 $1,924 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $151 |
| Janssen Biotech, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Nubeqa, TECVAYLI, Fabhalta, IMFINZI, VIVIMUSTA, KEYTRUDA.
Industry payments across NJ — which companies pay providers there.
